128 related articles for article (PubMed ID: 38309783)
1. Anti-GABA
Rusche T; Yaldizli Ö; Galbusera R; Mutke M; Halter JP; Lieb J; Matteazzi F; Stelmes A; Bittner J; Grzonka P; Frank N; Cordier D; Hench J; Frank S; Hirsch HH; Fischer U; Kuhle J; Sutter R; Rüegg S; Fisch U
Lancet; 2024 Feb; 403(10425):469-470. PubMed ID: 38309783
[No Abstract] [Full Text] [Related]
2. Isocitrate dehydrogenase inhibitor-driven differentiation may resemble secondary graft failure in post-allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia.
Rasche A; Mason EF; Strickland SA; Byrne M; Ferrell PB
Br J Haematol; 2021 Sep; 194(5):927-931. PubMed ID: 34096047
[No Abstract] [Full Text] [Related]
3. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L; Wang Y; Huang F; Fan Z; Xu Y; Sun J; Xu N; Deng L; Li X; Liang X; Luo X; Shi P; Liu H; Wang Z; Jiang L; Yu C; Zhou X; Lin R; Chen Y; Tu S; Huang X; Liu Q
Lancet Oncol; 2020 Sep; 21(9):1201-1212. PubMed ID: 32791048
[TBL] [Abstract][Full Text] [Related]
4. Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.
Ringdén O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M;
Br J Haematol; 2017 Feb; 176(3):431-439. PubMed ID: 27879990
[TBL] [Abstract][Full Text] [Related]
5. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J
Leuk Res; 2016 Aug; 47():22-5. PubMed ID: 27239737
[TBL] [Abstract][Full Text] [Related]
6. Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Davies JK; Hassan S; Sarker SJ; Besley C; Oakervee H; Smith M; Taussig D; Gribben JG; Cavenagh JD
Br J Haematol; 2018 Feb; 180(3):346-355. PubMed ID: 29076145
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
Pechey V; Parratt J; Vo L; Stevenson W
Int J Hematol; 2015 Feb; 101(2):203-6. PubMed ID: 25416235
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
Konuma T; Yanada M; Yamasaki S; Kuwatsuka Y; Fukuda T; Kobayashi T; Ozawa Y; Uchida N; Ota S; Hoshino T; Takahashi S; Kanda Y; Ueda Y; Takanashi M; Kanda J; Ichinohe T; Atsuta Y; Yano S
Br J Haematol; 2018 Jul; 182(2):245-250. PubMed ID: 29808919
[TBL] [Abstract][Full Text] [Related]
9. Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population-based cohort study.
Gjaerde LK; Jakobsen LH; Juhl-Christensen C; Olesen G; Petruskevicius I; Severinsen MT; Marcher CW; Theilgaard-Mönch K; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
Br J Haematol; 2023 Feb; 200(4):e40-e43. PubMed ID: 36263998
[No Abstract] [Full Text] [Related]
10. How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation.
Jiang S; Yan H; Lu X; Wei R; Chen H; Zhang A; Shi W; Xia L
Front Immunol; 2023; 14():1102966. PubMed ID: 37207218
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation.
Polchlopek Blasiak K; Simonetta F; Vargas MI; Chalandon Y
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29330269
[TBL] [Abstract][Full Text] [Related]
12. What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
Ringdén O; Labopin M; Sadeghi B; Mailhol A; Beelen D; Fløisand Y; Ghavamzadeh A; Finke J; Ehninger G; Volin L; Socié G; Kröger N; Stuhler G; Ganser A; Schmid C; Giebel S; Mohty M; Nagler A
J Intern Med; 2018 Feb; 283(2):166-177. PubMed ID: 29027756
[TBL] [Abstract][Full Text] [Related]
13. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.
Xuan L; Wang Y; Yang K; Shao R; Huang F; Fan Z; Chi P; Xu Y; Xu N; Deng L; Li X; Liang X; Luo X; Shi P; Liu H; Wang Z; Jiang L; Lin R; Chen Y; Tu S; Zhang Y; Sun J; Huang X; Liu Q
Lancet Haematol; 2023 Aug; 10(8):e600-e611. PubMed ID: 37414062
[TBL] [Abstract][Full Text] [Related]
15. Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Damiani D; Tiribelli M; Geromin A; Cerno M; Sperotto A; Toffoletti E; Simeone E; Michelutti A; Cavallin M; Fanin R
Ann Hematol; 2012 Dec; 91(12):1937-43. PubMed ID: 22893485
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
17. Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children.
Uden T; Bertaina A; Abrahamsson J; Ansari M; Balduzzi A; Bourquin JP; Gerhardt C; Bierings M; Hasle H; Lankester A; Mischke K; Moore AS; Nivison-Smith I; Pieczonka A; Peters C; Sedlacek P; Reinhardt D; Stein J; Versluys B; Wachowiak J; Willems L; Zimmermann M; Locatelli F; Sauer MG
Br J Haematol; 2020 May; 189(4):745-750. PubMed ID: 32012224
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia.
Bai L; Zhang YZ; Yan CH; Wang Y; Xu LP; Zhang XH; Zhang LP; Huang XJ; Cheng YF
BMC Cancer; 2022 Aug; 22(1):896. PubMed ID: 35974319
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.
Tang Y; Zhou Z; Yan H; You Y
Front Immunol; 2022; 13():810284. PubMed ID: 35185899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
